VICORE
Live / Registered — Registered (as of 06 Jul 2021)
What this means for you
Registered since 06 Jul 2021. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §71 affidavit of use is due by 06 Jul 2027, and its filing window is open now).
Record
- Serial number
- 79283880
- Registration number
- 6405658
- Mark type
- Word mark
- Filed
- 23 Jan 2020
- Published for opposition
- 19 Jan 2021
- Registered
- 06 Jul 2021
- Next maintenance filing
- §71 affidavit of use, due by 06 Jul 2027 (grace period to 06 Jan 2028)
- Attorney of record
- Sarah J. Schneider
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals and medical preparations for human use, namely, prescription drugs, namely, pills, tablets, capsules, caplets, and liquid drops sachets for the treatment fibrotic lung disease
- Class 042 — Scientific and technological services: Medical and pharmacological research services; medical and pharmacological research services within the fields of pulmonary diseases, cardiovascular diseases, autoimmune and inflammatory diseases, fibrotic diseases and kidney diseases; medical and pharmacological research services within the fields of pulmonary fibrosis, namely, ipf, pulmonary sarcoidosis and diffuse systemic sclerosis, in particular in the field of lung manifestations; pharmaceutical research and development; scientific research and development; medical research laboratory services; medical research; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical drug development services; pharmaceutical drug delivery system development services; pharmaceutical drug development services, namely, preparation and/or formulation of pharmaceuticals; medical product testing services; clinical research and professional expertise relating thereto in the nature of professional expertise in the field of clinical research for others; all of the foregoing services for the treatment of fibrotic lung disease
Owner
- Vicore Pharma AB, SE
- Vicore Pharma AB, SE
- Vicore Pharma AB, SE
Board proceedings on this mark
- Extension of Time to Oppose No. 79283880 — CareCore National LLC v. Vicore Pharma AB, filed 16 Feb 2021 (Terminated)
The owner also pleads this mark in 1 other Board proceeding.
Prosecution history
- 06 Jul 2026 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 22 Oct 2023 — NEW REPRESENTATIVE AT IB RECEIVED
- 21 Jan 2022 — NEW REPRESENTATIVE AT IB RECEIVED
- 23 Nov 2021 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 01 Nov 2021 — FINAL DISPOSITION NOTICE SENT TO IB
- 01 Nov 2021 — FINAL DISPOSITION PROCESSED
- 06 Oct 2021 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 06 Jul 2021 — REGISTERED-PRINCIPAL REGISTER
- 31 May 2021 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 16 Feb 2021 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 24 Jan 2021 — NOTIFICATION PROCESSED BY IB
- 19 Jan 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 19 Jan 2021 — PUBLISHED FOR OPPOSITION
- 30 Dec 2020 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 30 Dec 2020 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB